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Summary
Introduction: Mesenchymal stem cells (MSCs) are multipotent stem cells that have
the potential of proliferation, high self-renewal, and the potential of multilineage dif-
ferentiation. The differentiation potential of the MSCs in vivo and in vitro has
caused these cells to be regarded as potentially appropriate tools for wound healing.
After the burn, trauma or removal of the tumor of wide wounds is developed.
Although standard treatment for skin wounds is primary healing or skin grafting,
they are not always practical mainly because of limited autologous skin grafting.
Evidence Acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar,
PubMed (NLM), LISTA (EBSCO), and Web of Science have been searched.
Evidence Synthesis: For clinical use of the MSCs in wound healing, two key issues
should be taken into account: First, engineering biocompatible scaffolds clinical use
of which leads to the least amount of side effects without any immunologic
response and secondly, use of stem cells secretions with the least amount of clinical
complications despite their high capability of healing damage.
Conclusion: In light of the MSCs’ high capability of proliferation and multilineage
differentiation as well as their significant role in modulating immunity, these cells
can be used in combination with tissue engineering techniques. Moreover, the
MSCs’ secretions can be used in cell therapy to heal many types of wounds. The
combination of MSCs and PRP aids wound healing which could potentially be used
to promote wound healing.
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1 | INTRODUCTION
Regarding the function and suppressive property of mesenchymal
stem cells (MSCs), this article seeks to investigate the use of the MSCs
as a healing tool to treat wounds and their role in clinical use. Cur-
rently, different approaches are adopted to accelerate the process of
healing of normal wounds, diabetic ulcers, and burns, including the use
of antiseptics, antibiotics, cleaning wounds in different ways, appropri-
ate bandaging, and the use of electrical stimulation, ultrasound, mag-
netic waves, lasers, nanoparticles, some cytokines and growth factors,
and some chemical compounds.1,2 These treatments are costly and dif-
ficult to apply. Therefore, a novel therapeutic approach is needed to
heal chronic wounds. In the recent years, there has been a great inter-
est in the use of stem cells to treat different diseases. The MSCs are a
kind of stem cells that are currently being widely investigated. Stem
cell-based therapies have been reported to be successfully used to
heal and regenerate some tissues, and the MSCs have been demon-
strated to have many therapeutic capabilities. These multipotent stem
cells can differentiate into many types of the cells particularly mes-
enchymal cells such as fibroblasts, myoblasts, cardiac muscle, cartilage,
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and bone as well as some nonmesenchymal cells such as neurons and
hepatocytes. Besides that, they can produce certain growth factors
and cytokines that accelerate healing process at sites of damage.
Moreover, MSCs have been demonstrated to have the capability of
healing wounds in animal models and diabetic mice.3-5 Recent studies
have shown that these cells can obtain the phenotype of germ line
cells under appropriate induction conditions, which represents the
MSCs potential to differentiate nonmesenchymal cells. In addition to
being present in bone marrow, these cells are found in specialized tis-
sues such as skeletal muscle, adipose tissue, synovial membrane,
umbilical cord blood, and placenta.6-9
2 | PLATELET-RICH PLASMA
Platelet-rich plasma (PRP), also named autologous platelet gel, is prin-
cipally an increased concentration of autologous platelets suspended
in a small volume of plasma after centrifugation.10 PRP was first
defined in 2007 as a preparation of platelets present in a small volume
of plasma containing a large number of growth factors.11 PRP, which
can be simply isolated from whole blood, is regularly used for wound
healing. Recent findings proposed that platelet concentrates contained
multiple functional growth factors, and cytokines might be used as cell
therapy.12 Platelets are rich in many growth factors, including PDGF,
TGF-b1, VEGF, EGF, bFGF, and hepatocyte growth factor.13 Studies
have revealed that PRP may inhibit excessive early inflammation and
interact with macrophages to improve wound healing.14 Growth fac-
tors in platelets are generally in an inactive form, and they need to be
activated. A platelet gel is produced by activating PRP with thrombin
or CaCl2 to polymerize fibrinogen into a fibrin gel, which activates pla-
telets to release growth factors into the wound.15 Exogenous growth
factors have been used experimentally to change wound healing.
Effective delivery of the platelet-derived growth factors to a localized
site of injury is significant. Fibrin sealant and fibrin glue are two
methods for the sustained delivery of PRP-derived growth factors to
injured tissue. Fibrin sealants are intended to mimic the final steps of
the blood coagulation cascade, forming a stable, physiological fibrin
clot that assists homeostasis and wound healing. Fibrin sealants, which
have been accepted for hemostasis in the United States and Europe,
are occasionally utilized to promote wounds healing.16 Clinically, fibrin
sealant has caused a low rate of infection and stimulated healing.17
Fibrin glue provides a suitable carrier, which both delivers the growth
factors to the wound and releases them at a steady rate.18,19 The goal
of this study was to evaluate the use of MSCs alone or in combination
with PRP in the wound-healing process and an updated review of
stem cell applications in burns and wound healing.
3 | EVIDENCE SYNTHESIS
3.1 | Action mechanisms of the MSCs in wound
healing
Production and secretion of cytokines have been reported to be the
main functions of the MSCs in wound healing. The MSCs exert phar-
maceutical effects in healing wounds and lead to increase in colla-
gen, its proliferation, and migration as well as its secretion in human
dermal fibroblasts (HDFs) through activating them. Growth and
induction factors released from the MSCs activate keratinocytes and
dermal fibroblasts and contribute to wound healing through a para-
crine mechanism. The MSCs can play a role in wound healing in two
ways: first, differentiation into some other cells such as fibroblasts,
epithelium, and keratinocytes 20-23 and secondly, the effects induced
by paracrine that cause increase in angiogenesis, neovascularization,
de-epithelization, synthesis of collagen, and ultimately wound healing
through releasing various cytokines and growth factors Figure 1.
When stem cells are used for burn, their paracrine effects cause a
change in wound environment and the wound is healed. As well, the
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F IGURE 1 The mechanistic roles of MSCs in the wound healing. It has been proposed the mechanisms of acceleration of wound healing by
MSCs are as follows: (1) activate keratinocytes and dermal fibroblasts, (2) increase angiogenesis, neovascularization, de-epithelization, (3)
migration of macrophages and endothelial cells, (4) Secretion of chemokines particularly VEGF-b and PDGF,and (5) decrease in inflammatory cells
2 | MAHMOUDIAN-SANI ET AL.
stem cells are effective in cell differentiation.24-27 In vitro studies
have demonstrated that umbilical cord MSCs can differentiate into
keratinocytes and, therefore, have the potential to treat both autolo-
gous and homologous skin traumas.28,29 In vitro, the culture of the
MSCs contains large amounts of cytokines and growth factors that
can cause migration of macrophages and endothelial cells and there-
fore acceleration of wound-healing process.30 The MSCs have been
reported to be able to activate fibroblasts via paracrine and cause
acceleration of epithelialization. These cells were found to cause
acceleration of filling up the scratch wound in culture dishes of
fibroblasts and keratinocytes.31 The MSCs can differentiate into ker-
atinocytes and fibroblasts and therefore contribute to wound heal-
ing.23,32 Stem cells cause mitigation of scarring, acceleration of
wound closure, and increase in potential in wound healing.33 Besides
that, the MSCs can significantly accelerate wound healing when
accompanied by polylactic acid-caprolactone scaffold.34
3.2 | Molecular assessment of wound healing
Angiogenesis refers to the formation of new capillaries from previous
vessels which is necessary for wound healing. Angiogenesis is consid-
ered one of the most important events in wound healing. Ang-1, Ang-
2, VEGFa are angiogenic stimuli and play a fundamental part in the
process of wound healing. Histological examination and assessment
of formation of endothelial cell network using hematoxylin-eosin and
acridine orange staining, real-time PCR for Ang-1, Ang-2, VEGFa can
be used to investigate wound healing after use of the MSCs.35
3.3 | Mechanisms of the MSCs in immune
modulation
The MSCs play part in the process of wound healing in three phases:
inflammation, proliferation, and remodeling. The direct effect in mod-
ulating the immune response caused by proinflammatory factors such
as TNFa and IFNc and increasing the concentrations of anti-inflam-
matory factors including interleukin 10 and interleukin 4 are impor-
tant mechanisms of the MSCs which can be used to heal wounds
particularly chronic ones.36-38 Furthermore, studies have shown that
the MSCs secrete the known mediators of wound healing including
growth factors, cytokines, and chemokines particularly VEGF-b and
PDGF 30,39,40 Moreover, they release mytogenes that increase prolif-
eration of keratinocytes, skin fibroblasts, and endothelial cells.40,41
Studies on diabetic mice have indicated that the MSCs cause increase
in epithelialization and angiogenesis and therefore facilitate wound
healing.42 Moreover, the MSCs’ transfer on the surface of burn-
induced deep wounds causes a decrease in inflammatory cells, the
formation of new vessels, and granulation of the tissue.43
3.4 | Mesenchymal stem cells combined with PRP
for healing burn
Burn is one of the most common and destructive traumas, and its
treatment brings stupendous costs for healthcare systems
worldwide. It is highly necessary to conduct studies on the accelera-
tion of wound-healing process and re-epithelization for certain rea-
sons such as incomplete healing of burns, long-term treatments,
stupendous treatment costs, and burn-induced secondary complica-
tions.44 Conventional treatments for burn are washing the wound on
a daily basis, removing dead tissues, antibiotic bandaging till the for-
mation of granulation tissue, and transplantation. New generation
treatments consist of cell therapy and use of growth factors such as
platelet-derived ones.45 Within the past decade, cell therapy has
played a significant role in improving different diseases such as
burns. MSCs can exert pharmaceutical effects in repairing skin. In
light of the evidence on the differentiation of the MSCs into the
precursors of bone, adipose, and germ line in vitro, their confirmed
potential to produce specialized lines of different tissues as well as a
large number of studies with these cells, they can also be used to
treat burn wounds Table 3. Besides that, it can be recommended to
use platelet cryogel alongside the MSCs given platelet-derived
growth factors’ effect on the MSCs differentiation and proliferation.
This approach can relatively accelerate repair process and healing of
burn-induced wounds. Platelet gel is a plasma which is rich in throm-
bin and calcium-activated platelets that causes tissue repair, cell
migration, cell proliferation, angiogenesis, extracellular matrix synthe-
sis, and acceleration of epidermal, epithelial, and endothelial regener-
ation in treating burn.35,46,47 Platelet granules contain not only
growth factors but also some other biological compounds such as
serotonin, catecholamines, and antibacterial proteins.48,49 The MSCs
were used to treat burn in humans for the first time in 2005 in Rus-
sia. Five female patients were treated with allogeneic MSCs with
promising outcomes.20 A phase I and II clinical trials on allogeneic
cell therapy in patients with acute burn were started in China in
2011 to investigate umbilical cord MSCs’ efficacy in such patients.
The use of activated platelets is more efficacious than other stan-
dard treatments for acute wounds particularly burns.21 Transplanta-
tion of human umbilical cord (HUC)-MSCs can effectively help
improve burn wounds in mice. These findings provide a theoretical
basis to investigate the further clinical use of HUC-MSCs in burn
sites.22 In light of the above mentioned, the effects of the simultane-
ous use of platelet-derived growth factors and the MSCs in acceler-
ating the process of burn-induced wound healing have been less
frequently studied.
3.5 | Application of PRP and MSCs in skin wound
healing
Platelets produce certain factors such as PDGF and TGF-b that play
a role in proliferation, chemotaxis, and production of extracellular
matrices and angiogenesis41,42; in addition, VEGF and PDGF play a
fundamental role in hemostasis, cell proliferation, and wound heal-
ing.13,50-52 Platelet-derived platelet cryogel (PRP) is widely used in
wound healing.13,51,53 Platelet cryogel is used as a wound-healing
agent in facial surgery,54 healing of acute trauma-induced and cuta-
neous wounds, bone repair and regeneration,55 and healing of dia-
betic foot ulcers.56 When activated, the platelets present in the PRP
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secrete certain factors that cause an increase in the number of the
MSCs and their survival. These factors induce the S phase of cell
cycle and increase the number of the cells. Several studies have
demonstrated the optimal effect of PRP on the growth of adipose
tissue-derived MSCs57,58 and bone marrow-derived MSCs Table 1.59
Activation of PRB/Akt pathway is one of the molecular mechanisms
potentially involved in the increased growth of the MSCs.60 Inactiva-
tion of caspase-3 which is a key effective factor in apoptosis path-
way is another potentially involved mechanism.61 Umbilical cord-
derived PRP has recently been reported to have greater potential to
increase the growth of the MSCs. Another possible mechanism is
that the PRP causes an increase in cellularity at transplantation site
through increasing cell proliferation and utilizing the MSCs further.
Analysis of the secretions released from the platelets demonstrated
that the platelets released certain proteins that could contribute to
the phases of wound healing independently or in combination.56
Moreover, it has been demonstrated that mere use of some factors
such as PDGF is not much successful in wound healing (Tables 2
and 3).56,62
4 | DISCUSSION
Wound healing is a complex physiological process, which contains
numerous biological and molecular events such as cell migration and
proliferation, extracellular matrix (ECM) deposition, angiogenesis, and
remodeling.63 New approaches to promote wound healing mainly
depend on PRP, cell therapy, and 3-dimensional reconstruction to
facilitate angiogenesis and epithelial propagation and decrease inflam-
mation. Therefore, exploring new approaches to reduce the harm
caused by wound healing in humans is of central importance.64
Many studies have been conducted on the MSCs whose thera-
peutic use is one of their most important and difficult utilizations.
According to many studies that have been conducted on the MSCs,
we can briefly argue that these cells are particularly important from
therapeutic perspectives for certain reasons including being localized
at the inflammation site in tissue wounds after being injected, having
multilineage differentiation properties, and serving as multiple bioac-
tive molecules that are able to induce healing in damaged cells.
Thanks to certain differentiation properties, self-renewal, secretion of
TABLE 1 Effect of mesenchymal stem cells and platelet-rich plasma in wound healing
MSC source/Interven-
tions Study model Main results Ref
BM-MSCs, PRP Rat burn Histopathology of burn skin was improved in all treated groups
particularly MSCs pretreated with PRP 20 d after burn.
35
ADSCs, fibrin gels Rodent wounds mice ADSCs are able to form tubular structures within fibrin gels and may
also contribute to faster wound healing, as compared with no
treatment or to wounds treated with fibrin gels devoid of ADSCs.
75
BMSCs cultured in a
fibrin spray
Murine and Human Autologous bone marrow-derived MSC can be safely and effectively
delivered to wounds using a fibrin spray system.
76
Fibrin glue combined
with BMSCs
Scalded skin of rat Allogeneic BMSCs mixed with fibrin glue can contribute to the quick
formation of a film-like gel over the scald wounds, which might be of
significance for emergency treatment and skin-grafting operations.
77
ADSCs, PRP Fibroblast, keratinocyte
(in vitro)
Results propose an association between ADSC and PRP soluble
mediators, which could potentially be used to promote healing and re-
epithelialization in cutaneous ulcers.
69
Fetal mesenchymal
Stem, PRP
Patients suffering from
skin ulceration
PRP may act as a regulator of cell migration and wound healing. 72
MSCs isolated from
amniotic fluid, PRP
Neonatal foal (Severe
decubitus ulcers in a
septic neonatal foal)
Healing was faster using MSCs + PRP, and at 7 mo, an ulcer treated
with aloe gel was still not completely healed .
78
BM-MSCs, PRP on a
collagen matrix
Lewis rat This study shows that the addition of BM-MSCs to platelet-rich plasma
leads to a marked improvement, muscle survival along the scar edges
with improved collagen abundance and vascularization.
79
BM-MSCs, PRP Diabetic rat The combination of BMSCs and PRP aids diabetic wound healing. 71
MSCs, PRP Diabetic mice Animals treated with MSCs alone showed a similar level of re-
epithelialization of cutaneous lesions to those treated with MSC plus
PRP, and no significant difference was found between the two
treatments.
80
PB-MSCs, PRP Sheep (experimentally
injured deep digital
flexor tendons)
Results indicate that the combined use of PRP and MSCs did not
produce an additive or synergistic regenerative response and
highlighted the predominant effect of MSCs on tendon healing,
enhanced tissue remodeling, and improved structural organization.
81
ADSCs, adipose tissue-derived stem cells; BM-MSCs, bone marrow mesenchymal stem cells; MSCs, mesenchymal stem cells; PB-MSCs, peripheral
blood-derived MSCs; PRP, platelet-rich plasma.
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TABLE 2 Growth factors present in platelet-rich plasma and their functions62
Growth factor Source Functions
TGF Platelets, bone extracellular matrix, macrophages,
monocytes, and neutrophils
Stimulating undifferentiated mesenchymal stem cells, regulating
proliferation of endothelial cells, fibroblasts, and osteoclasts,
regulating synthesis of collagen, stimulating chemical absorption and
angiogenic properties, inhibiting the proliferation of macrophages and
lymphocytes.
bFGF Platelets, macrophages, mesenchymal cells Stimulating growth and differentiation of cartilage and bone cells,
proliferating mesenchymal cells.
PDGF Platelets, osteoclasts, endothelial cells, and
macrophages
Proliferating mesenchymal and bone cells, chemical adsorption, and
proliferating fibroblasts.
EGF Platelets, macrophages, and monocytes Stimulating chemical adsorption of vascular cells, regulating release of
collagen, stimulating the proliferation of mesenchymal and epithelial
cells.
VEGF Platelets and endothelial cells Increasing vascular permeability, stimulating the proliferation of
endothelial cells.
TABLE 3 Studies of mesenchymal stem cell-based therapies for wound healing and burn
MSC source/
Interventions Study model Main results Ref
ADSCs, activin B C57BL/6 mice Results showed that activin B was able to activate JNK and ERK signaling
pathways to induce actin stress fiber formation and ADSC migration to promote
wound healing.
82
ADSCs Rabbit Transplantation of ADSCs can promote the wound healing of skin-deep partial-
thickness scald wound of rabbit and shorten the wound-healing time.
83
hUCMSCs Balb/c mice Wound dressing model of hUCMSCs-alginate gel mix can promote wound healing
through paracrine signaling.
84
BM-MSCs,
seeded in a
collagen-
chitosan
sponge scaffold
Diabetic rats BM-MSCs exhibited a significant upregulated expression of proangiogenesis
factors, including HIF-1alpha, VEGF, and PDGF, following hypoxia pretreatment.
In vivo, hypoxia pretreatment of the skin substitute observably accelerated
wound closure via the reduction in inflammation and enhanced angiogenesis in
diabetic rats.
85
3-D graphene
foams loaded
with BM-MSCs
Rat Graphene foams scaffold could guide the wound-healing process with reduced
scarring, and the MSCs were crucial to enhance vascularization and provided a
better quality neoskin.
86
Epigallocatechin-
3-gallate, along
with MSCs
Rat EGCG, together with MSCs, can promote skin wound healing likely through their
combinational effects in modulating chronic inflammation.
87
MSCs, Chitosan
gel
Albino rat MSCs enhanced the healing process of wound closure more than chitosan gel
treatment. Furthermore, MSCs, injected intradermally, were more efficient in
accelerating wound healing than any other mode of treatment.
88
Placenta-derived
MSCs
Mice MSCs promote wound healing through release of proangiogenic factors as VEGF,
increase healing promoting factors as integrin beta1 and beta3, and decrease
proinflammatory cytokines as ICAM-1.
89
WJ-MSCs Mice Under experimental conditions, WJ-MSCs enhanced skin wound healing in an
in vivo mouse model.
90
AF-MSC ICR mice AF-MSC enhances wound healing through the increase in hypoxia-induced
paracrine factors via activation of TGF-beta/SMAD2 and PI3K/AKT pathways.
91
BM-MSCs Diabetic foot rat Healing process in diabetic rats was ameliorated by transplantation of BM-MSCs,
and this amelioration might be accounted for by the modification of keratinocyte
functions.
92
WJ-MSCs on
gelatin
microbeads
Balb/C mice hWJ-MSC can be expanded markedly in gelatin microbeads, while retaining MSC
surface marker expression, multipotent differential potential, and expression of
core transcription factors. These cells also efficiently enhanced skin wound
healing in vivo, in a manner comparable to that of hWJ-MSC obtained from 2D
culture.
93
(Continues)
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a wide spectrum of cytokines, a unique ability to bind to the damaged
cells, and migration to the sites of injury, the MSCs are considered
appropriate alternatives for cell therapy and gene therapy. Besides
that, these cells have been found to be suitable tools for some thera-
pies such as cell-based tissue engineering and wound healing because
of having immunity-modulating property. Recent studies have
enhanced out understanding of the MSCs to some extent and pro-
vided the evidence that these cells can be used as a promising tool to
treat different diseases especially wounds. In vitro findings on differ-
ent animal models and the clinical trials’ results have demonstrated
that the MSCs are suitable tools for wound healing.
Although the MSCs have been successfully utilized to treat dia-
betic ulcers, many studies have reported successful transplantation
of these cells in different cases, and even they have been used to
modulate immune system, these cells appear to have immunogenic
property and, in practice, the recipient’s immunosuppression should
be used to stabilize the transplantation of the MSCs.65 Moreover, a
number of studies have demonstrated that the mesenchymal cells’
effect on wound-healing process is mainly due to their secretion of
paracrine. It is, therefore, possible to not only use their advantages
but also resolve the potential problems related to the cells’ presence
in the body through removing the cells and using their secretions in
new therapeutic approaches.65,66 To heal diabetic ulcers in mice, an
optimal culture medium named conditioned medium, derived from
bone marrow MSCs, is used. In fact, this medium contains metabo-
lites, cytokines, growth factors, and extracellular matrix proteins that
are released into the medium by the mesenchymal cells. The effect
of this optimal culture medium in repairing certain tissues, especially
skin wounds, and the bone fracture has been reported.22,30,67 There-
fore, use of the factors secreted by autologous or homologous cells
seems the best approach to utilize the capabilities of the MSCs,
without being faced with their potential immunogenicity or tumori-
genicity problems, to heal skin wounds and diabetic ulcers. In a
study, this medium was prepared from the MSCs and used to heal
wounds in mice. This medium was found to be significantly effective
in healing wounds.68
4.1 | MSCs in combination with PRP for the
treatment of wound healing
Combined treatment of MSCs and PRP may increase fibroblasts and
keratinocytes in wound skin. Fibroblasts healing, remodel wounded
skin, and the migration of keratinocytes promote re-epithelialization
through the healing process.69 MSCs and PRP improve the
TABLE 3 (Continued)
MSC source/
Interventions Study model Main results Ref
BMSCs BALB/c mice CXCR4-overexpressing BMSCs migrate in an enhanced manner to skin wounds in
a SDF-1-expression-dependent manner, thereby reducing the skin wound-healing
time.
94
MSC C57BL/6 mice MSC-released TSG-6 was identified to improve wound healing by limiting Mphi
activation, inflammation, and fibrosis. TSG-6 and MSC-based therapies may thus
qualify as promising strategies to enhance tissue repair and to prevent excessive
tissue fibrosis.
95
BM-MSCs Burn in rat This study demonstrates the therapeutic effectiveness of intradermal application of
MSCs in a rat model of deep burns, providing basis for future regenerative
therapies in patients suffering from deep burn injuries.
96
MSC-seeded SIS Burn in rat Small intestinal submucosa (SIS) alone and MSC-seeded SIS were able to
accelerate the burn wound closure by enhancing granulation tissue formation,
increasing wound maturity, improving revascularization, and inducing the
proliferation of neoepidermal cells.
97
hUCMSCs Burns in rats hUCMSCs transplantation could suppress secondary inflammatory reaction by
lowering inflammatory cytokines after burning, thus, promoting wound healing
and scald repair.
98
BM-MSCs Mice model burn Results suggest that BM-MSC transplantation can effectively improve wound
healing in a mouse model of burn injuries.
99
hUCMSCs and
their exosomes
Rat skin burn model Results suggest that hUCMSCs -Ex-mediated Wnt4 induces b-catenin activation in
endothelial cells and exerts proangiogenic effects, which could be an important
mechanism for cutaneous wound healing.
100
Allogeneic MSC
and autologous
culture
Modified
monocytes
Porcine burn model A single application of allogeneic MSC improves the rate of burn wound healing
and improves the histological appearance of the burn wound.
101
3D, three-dimensional; ADSCs, adipose tissue-derived stem cells; AF-MSCs, amniotic fluid mesenchymal stem cells; BM-MSCs, bone marrow mesenchy-
mal stem cells; hUCMSCs, human umbilical cord mesenchymal stem cells; ICR mice, imprinting control region (ICR) mice; MSCs, mesenchymal stem cells;
TSG-6, TNF-stimulated gene 6; WJ-MSCs, Wharton’s Jelly-mesenchymal stem cells.
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degeneration of articular cartilage in the surgically induced
osteoarthritis animal model. MSCs and PRP treatment encourage the
downregulated expression of TNF-a compared to the diseased
group, and the combined treatment may be beneficial as an inflam-
matory regulator.70 The combined effect of MSCs and PRP has been
evaluated by Lian et al71 who found that the wound-healing rates
were significantly higher in the MSCs plus PRP group than in the
other groups. The synergistic effect of MSCs and PRP for the heal-
ing of refractory wound healing in a diabetic rat model was also
evaluated. MSCs plus PRP group showed 1.5-fold and 1.4-fold
higher TGF-b1 expression than PRP and MSCs alone, respectively.
This increased expression might promote the synthesis of collagen
proteins and integrin in fibroblasts and increased epithelial cell
migration. MSCs and PRP could induce a stronger angiogenic
response in healing wounds. Besides, wounds treated with MSCs
plus PRP revealed 12.5 blood vessels compared to 8 and 4.5 blood
vessels in wounds treated with MSCs alone and PBS.71 PRP concen-
trations stimulated proliferation and migration of adipose-derived
stem cells (ADSC) and fibroblasts in vitro. Furthermore, keratinocyte
proliferation could be stimulated by ADSC paracrine action. These
results suggested an association between ADSC and PRP soluble
mediators, which could potentially be used to promote healing and
re-epithelialization in wound healing.69The presence of PRP in the
amniotic fluid mesenchymal stem cells (AF-MSCs) medium substitut-
ing FBS resulted in an important stimulation of the migration ability
and the proliferation rate of AF-MSCs.72 The highly expressed fac-
tors such as PDGF and MMP9 in PRP appeared to act positively in
inducing migration of these cells. Reduction in SDF-1 a, which was
observed when MSCs were cultured with PRP, led to a decrease in
migratory capacity and theoretically an increase in MSC concentra-
tion within the wound bed.73,74 PRP and MSCs independently led to
increasing neovascularization in wounded tissues.29
5 | CONCLUSION
MSCs have been demonstrated to improve wound healing through
increased angiogenesis, re-epithelialization, and granulation tissue
formation. MSCs have an active role in the process of wound heal-
ing, acting via paracrine interactions, accelerating wound closure,
promoting resolution of wound inflammation, regulating extracellular
matrix remodeling, encouraging regeneration of skin with normal
construction and function, and suggesting great therapeutic poten-
tial. MSCs express keratinocyte-specific markers and high levels of
VEGF and Ang-1 suggest that MSCs promote wound healing by dif-
ferentiation and release of proangiogenic factors. PRP is employed
to wound healing, because of several growth factors crucial for heal-
ing, such as PDGF, TGF, IGF, and EGF, which are concentrated in
platelets. These factors not only regulate cell migration and prolifera-
tion but also remodel the extracellular matrix (ECM) and promote
angiogenesis, and create a useful environment that enhances wound
healing. PRP is a rich source of growth factors that stimulate angio-
genesis in wounds. PRP stimulates MSCs proliferation, preserves
MSCs multipotency, and does not interfere with any lineage differ-
entiation in a controlled nontumorigenic manner, a property that is
of high value not only for cell manufacturing but also for the clinical
applications. PRP may serve as a regulator of cell migration and
wound healing and promote MSCs migration and wound-healing
process. PRP may offer a suitable microenvironment for MSCs to
promote proliferation and differentiation. PRP can be a powerful tool
to attract cell populations, such as MSCs in the wound area. PRP
can be an alternate substitute for bovine serum for growing MSCs.
The use of MSCs, PRP, and MSCs together with PRP improves and
accelerates wound healing. PRP together with MSCs may represent
a promising approach for the treatment of wound healing.
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